FDA Approved: FLECTOR — Supplemental Application (IBSA Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for FLECTOR (diclofenac epolamine) submitted by IBSA Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain
• Soft Tissue Injuries
• Sprains
• Strains

Drugs mentioned

• FLECTOR (diclofenac epolamine)

Snippet

SUPPL AP for FLECTOR (DICLOFENAC EPOLAMINE)